Overview
Status
Active
Registry date
2019-10-01
Share capital
5,050.00 PLN
Registered address
ul. Prof. Stanisława Łojasiewicza 4, 30-348 Kraków, Poland
Financials
Only balance sheet data (assets and liabilities) is available. The income statement (P&L) is not available in the source filing for this period.
Revenue history
Filing timeliness
1 of 6 financial statements was filed late (for 2021, 62 days late).
- 202526/06/2026
- 202402/06/2025
- 202318/06/2024
- 202204/07/2023
- 202115/09/2022
- 202027/09/2021
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Industry
Authorized Representatives
Dominika Salamon – Attorney-in-fact (sole)
Tomasz Gosiewski – President of the Management Board
Manner of representation
Two members of the management board acting in agreement, or a commercial proxy acting together with a member of the management board; in the case of a one-person management board, the President of the Management Board personally.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Monika Kinga Brzychczy Włochage 50 | 15 | $202.59 | 14.8515% |
Małgorzata Urszula Bulandaage 75 | 15 | $202.59 | 14.8515% |
Tomasz Gosiewskiage 48 | 26 | $351.16 | 25.7426% |
| 15 | $202.59 | 14.8515% | |
Dominika Salamonage 51 | 15 | $202.59 | 14.8515% |
Agnieszka Sroka Oleksiakage 38 | 15 | $202.59 | 14.8515% |
Beneficial owners
| Person | Rights |
|---|---|
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| MedappS.A. | $3,351,163.61 | medapp.pl | ||
| EIT Rawmaterials Clc Eastsp. z o.o. | $1,795,803.10 | eitrawmaterials.eu | ||
| COS LabP.S.A. | $1,028,123.83 | coslab.pl | ||
| IntelliseqS.A. | $111,419.60 | intelliseq.pl | ||
| Przedsiębiorstwo Wielobranżowe Genezasp. z o.o. | $54,163.54 | geneza.eu | ||
| Medtransfersp. z o.o. | $21,666.01 | codete.com | ||
| Oncotherics PolandS.A. | $7,565.33 | oncotherics.com | ||
| Fusiomicasp. z o.o. | $5,263.98 | fusiomica.com | ||
| Ncage TherapeuticsS.A. | $29.14 | ncage.org | ||
| SelvitaS.A. | – | selvita.com |
Change history
| Date | Event | |
|---|---|---|
| 2024-11-12 | Share capital increase (5,000.00 PLN → 5,050.00 PLN) | |
| 2019-10-01 | Entered in the register |
FAQ
The main business activity of Sepgen focuses on research and experimental development on biotechnology.
The company was registered in the Polish National Court Register (KRS) on October 1, 2019.
The headquarters is located at: ul. Prof. Stanisława Łojasiewicza 4, 30-348 Kraków.
The share capital of the company is PLN 5,050 (approx. $1,364).
The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.
In 2024, the company's revenue reached $3,569.
Yes, in 2024 the company achieved a net profit of $1,943.
Last updated: 2026-07-09